Facility and Features

The Clinical Pharmacology Units operate under standard SOPs and management to ensure consistency and quality.

The geographically diverse sites allow Novum to accommodate multiclimatic conditions for studies involving transdermal products.
  • 200 Early Phase studies per year
  • 647-bed total
  • Confined and outpatient studies
  • Dedicated procedure areas
  • Over 30,000+ diverse participant database
  • Accessible to public transportation
  • Adjacent to universities and medical centers
  • Centralized atomic clock system
  • Schedule II-V: DEA Registration
  • Controlled Substance II – V Registration Certificate.
  • Limited-access Early Phase Units
  • Freezers: security-alarmed -80°C and -20°C
  • Negative-pressure dosing chamber